Olive Leaf Extract for Health & Longevity - Quick Reference Sheet
evipedia.aidev
← Back

Olive Leaf Extract for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4 – Audit

Olive leaf extract is a concentrated leaf product, not a stand-in for olive oil. The most coherent human signal is a modest blood-pressure drop when starting pressure is already high and daily amount matches hypertension trials. Blood-fat and insulin-handling shifts are mixed. Stomach upset, medicine stacking, and olive-pollen allergy are the practical harms. Not a settled or default longevity practice. (Full Review)

Protocol

Common trial dose
500–1,000 mg/day
Extract providing about 50–136 mg oleuropein; blood-pressure studies that lowered systolic pressure used ~1,000 mg or 500 mg twice daily
Time of day
Split morning and evening
If using 1,000 mg; a single morning dose is what several metabolic trials used
Competing styles
Distinct products, not one protocol
Frutarom/EFLA943 tablets, Comvita glycerite liquids, and BioActor 40% oleuropein capsules
Time to effect
Blood pressure
4–8 weeks
Trials re-measure then; modest drop mainly when starting pressure is already high
Blood lipids
4–8 weeks
Small lipid shift at trial doses in people with higher baseline lipids or pressure
HbA1c
12–14 weeks
Three-month blood-sugar average; recheck at 12 weeks, not 4

Benefits

Contraindications
  • Pregnancy and lactation
  • Known olive-pollen or Oleaceae allergy, including prior anaphylaxis (severe whole-body allergic reaction) to olive products
  • Baseline hypotension or recent unstable coronary syndromes until a clinician has a pressure baseline (resting systolic already <100 mmHg, or myocardial infarction within 90 days)
  • Unsupervised combination with two or more prescription antihypertensives when home systolic is already at or below target
    •
Key Interactions
  • Antihypertensive drugs (ACE inhibitors such as captopril, angiotensin-receptor blockers such as losartan, calcium-channel blockers, diuretics, beta blockers): additive systolic drop
  • Other hypotensive supplements (hibiscus, beetroot nitrate, aged garlic, magnesium in high dose, celery seed): same directional effect on pressure
  • Insulin, sulfonylureas (glipizide, glyburide), and other hypoglycemics including SGLT2 inhibitors (empagliflozin, dapagliflozin): theoretical extra glucose lowering
  • Anticoagulants and antiplatelets (warfarin, apixaban, aspirin, clopidogrel): in-vitro antiplatelet data only
  • CYP3A4 substrates (atorvastatin, some calcium-channel blockers, grapefruit-sensitive drugs): in-vitro CYP hints
  • Nonsteroidal anti-inflammatory drugs (NSAIDs such as ibuprofen, naproxen, aspirin): shared gastrointestinal upset
    •

Risk & Side Effects

  • Medium: Gastrointestinal Upset and Headache; Additive Blood Pressure Lowering
    •
  • Low: Additive Hypoglycemia Risk; Olive-Family Allergy
    •
  • Speculative: Bleeding Tendency; Cytochrome Enzyme Interactions; Mood Change at Extreme Dose
    •

Monitoring

Marker Target Why
Systolic / diastolic blood pressure 110–120 / 70–80 mmHg Primary expected effect and hypotensive risk
LDL cholesterol <80 mg/dL (<2.1 mmol/L) Possible modest LDL/triglyceride shift
Triglycerides <100 mg/dL (<1.1 mmol/L) Most consistent lipid signal in meta-analysis
Fasting glucose 75–90 mg/dL (4.2–5.0 mmol/L) Insulin-handling and hypoglycemia watch
HbA1c 5.0–5.3% Three-month glucose average
Fasting insulin 3–8 μIU/mL Captures sensitivity change when glucose is still normal
hs-CRP <1.0 mg/L Inflammation context; pooled extract data mixed
ALT Men 10–30 U/L; women 10–20 U/L Precautionary liver check

Cadence: Baseline, then 4 weeks and 12 weeks; every 3–6 months if numbers are stable. Home blood-pressure logs between draws

Qualitative Assessment

  • Standing tolerance: New dizziness on standing flags additive hypotension.
  • Gut comfort: Cramp or loose stool in week one often tracks dose and empty-stomach use.
  • Energy and training recovery: Athletic data ran against a recovery benefit.
  • Hot-flash or menopause symptom burden: Relevant only if that was the reason for use.
  • Home glucose logs: For people on insulin or sulfonylureas during the first two weeks.
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.